Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Rybicki

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 21, 2019
Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipientsAnita R Modi, Navneet S Majhail, Lisa Rybicki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplantsBrian T Hill, Brian J Bolwell, Lisa Rybicki, et al.
Palliative Medicine|March 9, 2007
Respiratory function during parenteral opioid titration for cancer painBassam Estfan, Fade Mahmoud, Philip Shaheen, et al.
Blood Cancer Journal|June 26, 2021
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapyRajshekhar Chakraborty, Lisa Rybicki, Jason Valent, et al.
Leukemia & Lymphoma|July 16, 2010
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remissionLisa Sproat, Brian Bolwell, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
British Journal of Haematology|February 29, 2020
Characterisation and prognostic impact of immunoparesis in relapsed multiple myelomaRajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, et al.
Clinical Hematology International|May 31, 2024
Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropeniaMariana Lucena, Kelly J Gaffney, Theresa Urban, et al.
Journal of Clinical Apheresis|August 6, 2019
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantationJack Khouri, Lisa Rybicki, Navneet S Majhail, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 21, 2019
Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipientsAnita R Modi, Navneet S Majhail, Lisa Rybicki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplantsBrian T Hill, Brian J Bolwell, Lisa Rybicki, et al.
Palliative Medicine|March 9, 2007
Respiratory function during parenteral opioid titration for cancer painBassam Estfan, Fade Mahmoud, Philip Shaheen, et al.
Blood Cancer Journal|June 26, 2021
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapyRajshekhar Chakraborty, Lisa Rybicki, Jason Valent, et al.
Leukemia & Lymphoma|July 16, 2010
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remissionLisa Sproat, Brian Bolwell, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
British Journal of Haematology|February 29, 2020
Characterisation and prognostic impact of immunoparesis in relapsed multiple myelomaRajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, et al.
Clinical Hematology International|May 31, 2024
Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropeniaMariana Lucena, Kelly J Gaffney, Theresa Urban, et al.
Journal of Clinical Apheresis|August 6, 2019
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantationJack Khouri, Lisa Rybicki, Navneet S Majhail, et al.
Pageof 12